CASP9 and lung cancer: Our qRT-PCR results indicated that Odo A treatment led to upregulation of CASP3, CASP7, CASP8, and CASP9 expression, which suggests that the extrinsic route was responsible for blocking the development of lung cancer cells (Figure 2A).